BMY vs ITIC · P/E 17, rev $24.46B vs P/E 12, rev $150.5M
Bristol-Myers Squibb Company (BMY) versus Investors Title Company (ITIC) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Investors Title Company (ITIC) is a insurance - specialty company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported ITIC revenue for 2026-06-30 was $150.5M. Net income was $20.7M. ITIC currently screens at market cap $437.7M and trailing P/E 11.5.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. ITIC currently screens at market cap $437.7M and trailing P/E 11.5.
Not investment advice. Open the BMY and ITIC stock pages for the full models.
Not investment advice.